Nicholas Scarlott
About Nicholas Scarlott
Nicholas Scarlott is a scientist specializing in biochemistry and environmental science, currently working as Scientist 1 at Sangamo Therapeutics, Inc. He has a strong background in developing novel therapies for rare genetic diseases and has authored publications on zinc finger technology and genome editing.
Current Role at Sangamo Therapeutics
Nicholas Scarlott currently serves as Scientist 1 at Sangamo Therapeutics, Inc. in Richmond, California. He has held this position since 2021, contributing to the company's mission of advancing science for patients with rare genetic diseases. His work involves the development of novel therapies through innovative protein modifications.
Previous Experience at Sangamo Therapeutics
Prior to his current role, Scarlott held multiple positions at Sangamo Therapeutics, Inc. He worked as Research Associate 1 from 2015 to 2017, Research Associate 2 from 2017 to 2018, Research Associate 3 from 2019 to 2020, and Research Associate 4 from 2020 to 2021. His progressive roles reflect his growing expertise in the field of biotechnology and gene editing.
Education and Expertise
Nicholas Scarlott graduated with a double Bachelor of Science in Biochemistry and Environmental Science from Northeastern University, completing his studies from 2008 to 2013. He furthered his education at The Johns Hopkins University, where he earned a Master of Science in Biotechnology from 2015 to 2017. His educational background provides a strong foundation for his research in genetic therapies.
Research Contributions and Publications
Scarlott has made significant contributions to the field of gene editing, particularly in the development of modular integrases for precise genomic integration. He has authored scientific publications on zinc finger technology and its applications, focusing on enhancing gene editing specificity and diversifying the structure of zinc finger nucleases. His research also includes work on engineered zinc finger protein transcription factors for persistent repression of tau in the brain.
Early Career Experience
Before his tenure at Sangamo Therapeutics, Nicholas Scarlott gained valuable experience in various roles. He worked as a Research Assistant at Woods Hole Oceanographic Institution in 2010 and as a Manufacturing Bioprocess Technician at Bayside Solutions from 2013 to 2015. He also completed a research internship at Prosetta Corporation in 2013. These positions contributed to his practical knowledge in scientific research and biotechnology.